Stocks and InvestingStocks and Investing
Wed, January 12, 2022
Tue, January 11, 2022
Mon, January 10, 2022
Sun, January 9, 2022
Fri, January 7, 2022

David Amsellem Upgraded (AMPH) to Buy and Increased Target to $28 on, Jan 7th, 2022


Published on 2024-10-27 19:11:54 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Upgraded "Amphastar Pharmaceuticals, Inc." (AMPH) to Buy and Increased Target from $21 to $28 on, Jan 7th, 2022.

David, nor any peers, have made any analyst calls on AMPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30